標題: Titlebook: Disruptive Psychopharmacology; Frederick S. Barrett,Katrin H. Preller Book 2022 The Editor(s) (if applicable) and The Author(s), under exc [打印本頁] 作者: 使委屈 時間: 2025-3-21 16:35
書目名稱Disruptive Psychopharmacology影響因子(影響力)
書目名稱Disruptive Psychopharmacology影響因子(影響力)學科排名
書目名稱Disruptive Psychopharmacology網(wǎng)絡公開度
書目名稱Disruptive Psychopharmacology網(wǎng)絡公開度學科排名
書目名稱Disruptive Psychopharmacology被引頻次
書目名稱Disruptive Psychopharmacology被引頻次學科排名
書目名稱Disruptive Psychopharmacology年度引用
書目名稱Disruptive Psychopharmacology年度引用學科排名
書目名稱Disruptive Psychopharmacology讀者反饋
書目名稱Disruptive Psychopharmacology讀者反饋學科排名
作者: 美學 時間: 2025-3-21 20:40 作者: 放肆的我 時間: 2025-3-22 02:08 作者: 貝雷帽 時間: 2025-3-22 05:16 作者: 殖民地 時間: 2025-3-22 09:16
Book 2022apies are a sharp departure from more traditional models of psychotherapy and pharmacotherapy for psychiatric and other medical disorders. This may be critical to their success. The current volume provides a comprehensive review of the state of the science of psychedelic therapies, including discuss作者: 偏狂癥 時間: 2025-3-22 13:38 作者: 偏狂癥 時間: 2025-3-22 17:37 作者: 使?jié)M足 時間: 2025-3-23 01:11
Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approachxamining the effects of psilocybin therapy for patients with major depressive disorder and treatment-resistant depression. Insights from functional magnetic resonance imaging and qualitative analyses are also presented, as well as a discussion of study limitations and future directions for the research.作者: 阻塞 時間: 2025-3-23 03:23
Psychedelics and Anti-inflammatory Activity in Animal Models anti-inflammatory strategy. This review will describe recent findings regarding psychedelics as anti-inflammatory compounds, as well as parse out differences in functional selectivity and immune regulation that exist between a number of well-known hallucinogenic compounds.作者: 正常 時間: 2025-3-23 08:33
Contexts of Science: Sciences of Science day after the ayahuasca intervention. In addition, we have explored the nature of these effects using multivariate measures. In this article, we will review the history, pharmacology, clinical trials, and clinical and behavioral markers associated with the antidepressant effects of ayahuasca.作者: 記憶法 時間: 2025-3-23 11:42 作者: 沒有希望 時間: 2025-3-23 15:17
Ayahuasca for the Treatment of Depression day after the ayahuasca intervention. In addition, we have explored the nature of these effects using multivariate measures. In this article, we will review the history, pharmacology, clinical trials, and clinical and behavioral markers associated with the antidepressant effects of ayahuasca.作者: 我的巨大 時間: 2025-3-23 21:49 作者: 利用 時間: 2025-3-24 00:04 作者: 收養(yǎng) 時間: 2025-3-24 03:04
Foundations for Training Psychedelic Therapistscludes 12 curricular areas and didactic methods that support the therapist’s process of growth. Finally, the authors link their training philosophy to the current needs of society, offering a vision of how to express psychedelic integration through the honoring of diversity and collaboration.作者: Preamble 時間: 2025-3-24 10:11
Psychedelics in the Treatment of Headache and Chronic Pain Disordersuired to address disease-specific treatments, uncover mechanism(s) of action, and verify safety. In this chapter, these topics are reviewed with particular attention to the neurobiological systems that offer potential sources of psychedelics’ unique clinical effects in headache and pain.作者: Blemish 時間: 2025-3-24 12:44
Book 2022ion of models and approaches to psychedelic therapies as well as the current status of safety and efficacy data for mood, substance use, trauma, obsessive-compulsive, neurodevelopmental, neurodegenerative disorders, neurological, and inflammatory disorders.作者: Cleave 時間: 2025-3-24 16:20 作者: 擴音器 時間: 2025-3-24 20:48 作者: neurologist 時間: 2025-3-25 00:19
Frederick S. Barrett,Katrin H. PrellerSummarizes the state of the science of safety and efficacy of psychedelic therapies.Reviews theoretical models and approaches to psychedelic therapies.Treats both theoretical and practical aspects of 作者: 疾馳 時間: 2025-3-25 03:47 作者: HUSH 時間: 2025-3-25 08:50 作者: 描繪 時間: 2025-3-25 12:44 作者: Albinism 時間: 2025-3-25 18:16 作者: browbeat 時間: 2025-3-25 23:10 作者: DEFER 時間: 2025-3-26 04:05
The Cognitive Neuroscience of Metacognition purposes. In psychotherapy, group treatment started soon after developing psychoanalytic treatment procedures. For psychedelic therapy however, individual treatment guided by one or sometimes even two therapists is the most common and widespread treatment model for clinical research and therapy thu作者: Armada 時間: 2025-3-26 04:46 作者: GULP 時間: 2025-3-26 11:58
Kieran C. R. Fox,Kalina Christoffngly to influence the dialog around neurodiversity, the experience of being autistic, and the effectiveness of mental health interventions for autistic adults. Autistic self-advocates are speaking up in support of including neurodivergent adults as a population that might benefit from the burgeoning作者: Deduct 時間: 2025-3-26 15:24 作者: 原始 時間: 2025-3-26 19:12 作者: Meander 時間: 2025-3-27 00:25 作者: ABHOR 時間: 2025-3-27 04:43
https://doi.org/10.1007/978-1-349-09988-7t research into other novel rapid-acting antidepressants – most notably serotonergic psychedelics (SPs) – has also proven promising. Presently, the mechanisms of action of these substances are under investigation to improve these novel treatments, which also exhibit considerable side effects such as作者: 無辜 時間: 2025-3-27 08:10 作者: Coterminous 時間: 2025-3-27 10:44
https://doi.org/10.1007/978-94-015-7825-7is high unmet need, recent results reporting beneficial outcomes of psychedelic-assisted therapy in SUD are particularly relevant. However, several questions remain with regard to this treatment approach. The clinical mechanisms of action of psychedelic substances in the treatment of SUD are not wel作者: geometrician 時間: 2025-3-27 15:17
The Units of Analysis of Science Studieso use disorder. I review historical research from the 1950s to 1970s suggesting that classic psychedelics are associated with addiction recovery across pharmacologically distinct drugs of addiction. I then review anthropological reports about ceremonial use of classic psychedelics and epidemiologica作者: 狂熱語言 時間: 2025-3-27 20:10
Steve Fuller,Marc Mey,Steve WoolgarHT. receptor is the most widely expressed mammalian serotonin receptor and is found in nearly every examined tissue type including neural, endocrine, endothelial, immune, and muscle, suggesting it could be a novel and pharmacological target for several types of disorders. Despite this, the bulk of r作者: 敵手 時間: 2025-3-27 23:10 作者: conscience 時間: 2025-3-28 03:20
William R. Shadish Jr.,Robert A. Neimeyerorts, which have paved the way for the first controlled studies of psilocybin and lysergic acid diethylamide (LSD) in these disorders. The reported lasting clinical effects after limited dosing with psychedelics present a novel means for disease management, but considerable further study will be req作者: 邊緣帶來墨水 時間: 2025-3-28 06:27
The Cold War and the 1984 Olympic Gamessts psychedelics can exert persisting anxiolytic and antidepressant effects lasting up to several months after a single administration. Data indicate acute subjective drug effects as important psychological factors involved in observed therapeutic benefits. Additionally, animal models have shown an 作者: 彩色的蠟筆 時間: 2025-3-28 11:01
https://doi.org/10.1007/978-3-030-11999-7ritical need for innovative approaches. We provide an overview of trauma and PTSD and cite literature providing converging evidence of the therapeutic potential of psilocybin for PTSD. No study to date has investigated psilocybin or psilocybin-assisted psychotherapy (PAP) as treatments for PTSD. An 作者: Flavouring 時間: 2025-3-28 18:28
Dosing Psychedelics and MDMAly 3,4-methylenedioxymethamphetamine, have received renewed attention in psychiatric research and may be developed into medications for such indications as anxiety, depression, cluster headache, and posttraumatic stress disorder, among others. However, identifying proper doses is crucial. Controlled作者: Abrade 時間: 2025-3-28 20:17 作者: 手勢 時間: 2025-3-29 02:33 作者: Desert 時間: 2025-3-29 05:07 作者: 松軟 時間: 2025-3-29 11:06
Foundations for Training Psychedelic Therapistsering the disconnected parts of ourselves and reestablishing fundamental trust. The authors then walk through six therapist competencies that describe the root principles of practice, breadth of knowledge, transpersonal perspective, and therapeutic stance of a psychedelic practitioner. This model in作者: Systemic 時間: 2025-3-29 13:39
Ayahuasca for the Treatment of Depression (.), with leaves from a shrub in the coffee family . (.). Mixed with water and boiled for hours or days, it produces a brownish-colored liquid with a strong and characteristic taste. Ayahuasca contains the psychedelic tryptamine N,N-Dimethyltryptamine (DMT), and Monoamine Oxidase Inhibitors (MAOi),作者: saturated-fat 時間: 2025-3-29 16:44
Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approachral lines of evidence from early-phase experimental trials suggest that serotonergic psychedelics, particularly psilocybin, with therapeutic support show great promise in the treatment of depression with large effect sizes. Neuroimaging data have also revealed the dynamic effects of psilocybin on fu作者: 淡紫色花 時間: 2025-3-29 23:21
Ketamine for Depression: Advances in Clinical Treatment, Rapid Antidepressant Mechanisms of Action, t research into other novel rapid-acting antidepressants – most notably serotonergic psychedelics (SPs) – has also proven promising. Presently, the mechanisms of action of these substances are under investigation to improve these novel treatments, which also exhibit considerable side effects such as作者: Adenocarcinoma 時間: 2025-3-30 03:22
The Potential of Psychedelics for End of Life and Palliative Caretexts remain limited. In particular, psychological factors such as depression, existential distress, and well-being remain challenging to address with current medications. Here, we review recent research on the use of psychedelics in clinical settings with a particular focus on patients with life-th作者: 執(zhí)拗 時間: 2025-3-30 06:58
Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Actionis high unmet need, recent results reporting beneficial outcomes of psychedelic-assisted therapy in SUD are particularly relevant. However, several questions remain with regard to this treatment approach. The clinical mechanisms of action of psychedelic substances in the treatment of SUD are not wel作者: Instrumental 時間: 2025-3-30 09:55
Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessationo use disorder. I review historical research from the 1950s to 1970s suggesting that classic psychedelics are associated with addiction recovery across pharmacologically distinct drugs of addiction. I then review anthropological reports about ceremonial use of classic psychedelics and epidemiologica作者: 和藹 時間: 2025-3-30 16:12
Psychedelics and Anti-inflammatory Activity in Animal ModelsHT. receptor is the most widely expressed mammalian serotonin receptor and is found in nearly every examined tissue type including neural, endocrine, endothelial, immune, and muscle, suggesting it could be a novel and pharmacological target for several types of disorders. Despite this, the bulk of r作者: 竊喜 時間: 2025-3-30 17:59
Psilocybin for the Treatment of Obsessive-Compulsive Disorderse and alternatives merit priority attention. Psilocybin may represent a safe and effective avenue for treatment of individuals affected by this condition. In this chapter we briefly introduce OCD symptoms, epidemiology, as well as relevant hypotheses on the mechanism of disease that may inform treat作者: Handedness 時間: 2025-3-30 22:42 作者: 開始從未 時間: 2025-3-31 04:29
Psychedelics as Novel Therapeutics in Alzheimer’s Disease: Rationale and Potential Mechanismssts psychedelics can exert persisting anxiolytic and antidepressant effects lasting up to several months after a single administration. Data indicate acute subjective drug effects as important psychological factors involved in observed therapeutic benefits. Additionally, animal models have shown an 作者: UTTER 時間: 2025-3-31 05:40
Psilocybin for Trauma-Related Disordersritical need for innovative approaches. We provide an overview of trauma and PTSD and cite literature providing converging evidence of the therapeutic potential of psilocybin for PTSD. No study to date has investigated psilocybin or psilocybin-assisted psychotherapy (PAP) as treatments for PTSD. An 作者: Matrimony 時間: 2025-3-31 11:09 作者: 蓋他為秘密 時間: 2025-3-31 17:01
Effects of Setting on Psychedelic Experiences, Therapies, and Outcomes: A Rapid Scoping Review of thn psychedelic therapies, as well as consistent interest in theorizing about these effects. However, this consensus has yet to generate consistent, prospective, rigorous tests of setting and its complexities. As a result, the field continues to lack understanding or agreement regarding the effects of
